Waters Corp (WAT)
Waters Corporation (WAT) is a global provider of analytical technologies, primarily serving the life sciences, pharmaceutical, and biopharmaceutical markets. Founded in 1958, the company specializes in laboratory instruments, software, and consumables used in scientific research, quality testing, and drug development. Waters is known for its chromatography and mass spectrometry systems, which enable precise and accurate analysis of complex samples.
Company News
The global chromatography market in pharmaceuticals and biotechnology is projected to grow from $13.3 billion in 2025 to $19.8 billion by 2030, with an 8.4% CAGR, driven by rising biopharmaceutical innovations, regulatory standards, and demand for generics and biosimilars.
Becton Dickinson will combine its Biosciences & Diagnostic Solutions business with Waters Corporation in a $17.5 billion tax-efficient Reverse Morris Trust transaction, expected to close by Q1 2026.
Waters (WAT) reported a 4.3% decline in revenue and a 6.1% decrease in EPS for Q2 2024 compared to the same period last year. The company's performance was mixed across its divisions, with the Water division and TA division seeing declines, while the service business saw growth.
High returns on invested capital can be useful for narrowing down a list of stocks for investment.
